Health Condition 1: C241- Malignant neoplasm of ampulla of Vater Health Condition 2: C170- Malignant neoplasm of duodenum Health Condition 3: C240- Malignant neoplasm of extrahepaticbile duct Health Condition 4: C250- Malignant neoplasm of head of pancreas Health Condition 5: K861- Other chronic pancreatitis
Conditions
Interventions
Intervention1: Synbiotic capsule containing a fixed combination of 6 probiotics and one prebiotic
Sl No Item Dosage
P
Sponsors
All India Institute of Medical Sciences, Jodhpur
Eligibility
Inclusion criteria
Inclusion criteria: The patients who undergo pancreatoduodenectomy for any indication and consent for the study
Exclusion criteria
Exclusion criteria: 1. The patients who undergo pancreatoduodenectomy for any indication but refuse consent 2. The patients who undergo pancreatoduodenectomy for any indication but received therapeutic antibiotics for 1 week preceding the date of surgery, for any active infection like pneumonia, cholangitis etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Any post-pancreatoduodenectomy infective complications like surgical site infection, pneumonia, intra-abdominal abscess/collection, urinary tract infection, central-line associated infection, bacteremia, fungemia etcTimepoint: 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess length of ICU and hospital stayTimepoint: Post-operative day when patient was shifted out of ICU and discharged from ward;To assess postoperative non-infectious morbidity Timepoint: 30 days | — |
Countries
India
Contacts
Public ContactDr Selvakumar B
Department of Surgical Gastroenterology
Outcome results
None listed